Irresponsible research? Dis/qualifying the gene editing of human embryos
This paper examines current controversies around the use of gene editing on human embryos. Gene editing techniques (such as CRISPR/Cas9) have raised numerous questions to do with governance, security, control, legislation, regulation, ethics, responsibility, and economics. While the controversy around CRISPR/Cas9 is multifaceted and multi-layered, I focus in this paper on one key issue, namely the characterizations of, and demarcations between, responsible research and irresponsible research.